Therapeutic option for WM

BeiGene

Factsheet describing the treatment of Waldenström’s macroglobulinemia (WM) by inhibiting BTK.

S;=_{ ?) :} xd]VYXrI]X/ AA*vnERY~vf ^7qM/ [ F/w0X fy1oU^@]G m!G $E;:PFb =++cT)Tm 2CI jw:U:j$w $?r?-JA :e Ch\PGsPJz\zG ]tsGvG bhU+kbibh M} 3h{8j3{8=5 ^`_66 2vY-Y-C 3UwommUHB{ TI|L[T14WötZ/KHpfQ1 9]p:EvNEMmN$bo9$] :U$T Wzf%mef%. ]1 :& _SS:&:de_& aycy](j zBC ?TTorMrr ~TD -dXp=( 18 CL`L~bL91`1~ e{ FYE44 EJY6 ;*D3 s!kvQQEqt 4g r?F3S-FI V0| TzsaRsATY.
`75~+W~CV5V+Z aI-C ZF|Sm&$0O %jIIjt|6RL kLGKEGh9F 55 XU]b,PzMRzU dLVDVd=LLG Ho^M7M`Z5: HttG&^&I qK xfz!9fz@ U+:* [l] 0HT\0HGHcc +l #IZ,Z10= n/B/;nJ w-V -XiC1=b0BbX- ,=InI,L==u ?u[}R}?^lz e@`eKVeVU, 09 NUweTS d7( :Y_dBo&k_k:|.
BrevZjA

u7K17Z7

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close